Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	75,844	67,908	39,418	24,999	-	-
Market Cap Growth	36.47%	72.28%	57.68%	-	-	-
Enterprise Value	79,413	70,778	40,892	26,947	-	-
Last Close Price	836.75	747.23	431.60	272.67	-	-
PE Ratio	28.48	24.93	18.17	12.92	-	-
PS Ratio	3.90	3.21	2.13	1.29	-	-
PB Ratio	3.81	3.41	2.24	1.60	-	-
P/TBV Ratio	4.01	3.59	2.35	1.65	-	-
P/FCF Ratio	-	-	64.89	16.89	-	-
P/OCF Ratio	-	20.48	18.22	9.99	-	-
EV/Sales Ratio	4.08	3.35	2.21	1.39	-	-
EV/EBITDA Ratio	17.18	15.59	10.75	7.88	-	-
EV/EBIT Ratio	21.36	18.75	13.07	9.64	-	-
EV/FCF Ratio	-	-	67.31	18.21	-	-
Debt / Equity Ratio	0.21	0.21	0.16	0.14	0.25	0.08
Debt / EBITDA Ratio	0.89	0.92	0.74	0.63	1.65	-
Debt / FCF Ratio	-	-	4.70	1.46	-	-
Asset Turnover	-	0.77	0.77	0.91	1.18	-
Inventory Turnover	-	1.91	1.70	2.24	-	-
Quick Ratio	-	0.98	0.90	0.86	0.80	11.42
Current Ratio	-	2.01	1.94	1.94	1.77	11.42
Return on Equity (ROE)	-	14.54%	13.08%	13.14%	17.63%	-2.00%
Return on Assets (ROA)	-	8.60%	8.10%	8.16%	10.10%	-1.15%
Return on Capital (ROIC)	10.51%	10.60%	10.25%	9.98%	11.92%	-1.16%
Return on Capital Employed (ROCE)	-	16.80%	16.60%	17.00%	11.30%	-
Earnings Yield	3.51%	4.01%	5.50%	7.74%	-	-
FCF Yield	-	-1.04%	1.54%	5.92%	-	-
Dividend Yield	0.60%	0.67%	0.69%	0.73%	-	-
Payout Ratio	-	11.64%	8.36%	9.37%	-	-
Buyback Yield / Dilution	-0.05%	-0.07%	-0.01%	-	-36150.40%	-
Total Shareholder Return	0.55%	0.60%	0.69%	0.73%	-36150.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.